Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
ECB Bancorp
ECBK
$180M
| $456K | ﹤0.01% |
35,100
+2,800
| +9% | +$36.5K |
|
|
QVCGA
2902
DELISTED
QVC Group Inc Series A
QVCGA
| $453K | ﹤0.01% |
7,371
-13,910
| -65% | -$727K |
|
|
DMRA
2903
Damora Therapeutics, Inc. Ordinary Shares
DMRA
$1.78B
| $452K | ﹤0.01% |
23,159
+6,880
| +42% | +$122K |
|
2904
Dimensional Core Fixed Income ETF
DFCF
$10.8B
| $449K | ﹤0.01% |
10,700
-1,571
| -13% | -$66K |
|
2905
KLX Energy Services
KLXE
$45M
| $449K | ﹤0.01% |
58,000
+19,200
| +49% | +$172K |
|
2906
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$563M
| $449K | ﹤0.01% |
5,400
-6,700
| -55% | -$501K |
|
2907
Superior Group of Companies
SGC
$185M
| $449K | ﹤0.01% |
27,200
+15,600
| +134% | +$225K |
|
|
ALTM
2908
DELISTED
Arcadium Lithium plc
ALTM
| $449K | ﹤0.01% |
+104,200
| New | +$523K |
|
2909
Aura Biosciences
AURA
$725M
| $448K | ﹤0.01% |
57,100
+28,600
| +100% | +$237K |
|
|
DX
2910
Dynex Capital
DX
$3.15B
| $447K | ﹤0.01% |
35,900
-258,300
| -88% | -$3.2M |
|
2911
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$5.49B
| $447K | ﹤0.01% |
12,700
-28,200
| -69% | -$951K |
|
2912
ProShares Ultra Dow30
DDM
$542M
| $444K | ﹤0.01% |
10,200
-79,400
| -89% | -$3.26M |
|
2913
Douglas Dynamics
PLOW
$1.02B
| $444K | ﹤0.01% |
18,400
-36,300
| -66% | -$919K |
|
2914
ProShares Short Russell2000
RWM
$132M
| $443K | ﹤0.01% |
22,100
-4,700
| -18% | -$100K |
|
2915
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.1B
| $443K | ﹤0.01% |
+1,700
| New | +$418K |
|
2916
Comstock
LODE
$208M
| $439K | ﹤0.01% |
120,581
+13,370
| +12% | +$60.3K |
|
2917
Spire
SR
$4.72B
| $436K | ﹤0.01% |
+7,100
| New | +$425K |
|
2918
Ebang International Holdings
EBON
$12.3M
| $435K | ﹤0.01% |
44,813
+600
| +1% | +$6.14K |
|
2919
Retractable Technologies
RVP
$19.8M
| $431K | ﹤0.01% |
358,893
+110,319
| +44% | +$134K |
|
2920
Agios Pharmaceuticals
AGIO
$1.79B
| $430K | ﹤0.01% |
14,714
-28,000
| -66% | -$750K |
|
|
HLVX
2921
DELISTED
HilleVax
HLVX
| $429K | ﹤0.01% |
+25,800
| New | +$413K |
|
2922
FVCBankcorp
FVCB
$335M
| $428K | ﹤0.01% |
35,175
+2,300
| +7% | +$28.6K |
|
2923
Intellicheck
IDN
$73.1M
| $428K | ﹤0.01% |
122,900
-33,200
| -21% | -$63.7K |
|
2924
Fidelity D&D Bancorp
FDBC
$306M
| $426K | ﹤0.01% |
8,800
+100
| +1% | +$4.92K |
|
2925
Gevo
GEVO
$360M
| $426K | ﹤0.01% |
554,700
-601,100
| -52% | -$523K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.